SPY328.79+2.27 0.70%
DIA266.72+2.37 0.90%
IXIC10,902.80+157.52 1.47%

Bank of America Reiterates Buy on NextCure, Lowers Price Target from $92 to $89; Sees Data Presented At SITC As 'Incrementally Positive'

Bank of America reiterates NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $92 to $89.

Benzinga · -

Bank of America reiterates NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $92 to $89.